Cheelcare Announces Medicare and Medicaid Services Reimbursement Approval for Companion Power Assist Device, Expanding U.S. Market Access
NEUPATH HEALTH ANNOUNCES EXECUTIVE LEADERSHIP CHANGES AS PART OF PLANNED TRANSITION, PRE-ANNOUNCES STRONG 2025 RESULTS
BioNxt Accelerates ODF for Multiple Sclerosis Toward Human Clinical Study with >40% Bioavailability Improvement and Myasthenia Gravis Expansion
Onco-Innovations arranges $2-million private placement
Onco-Innovations Announces Private Placement
Jack Nathan names co-founder Di Cesare as interim CEO
Tempramed Technologies releases VIVI Med
Jack Nathan Medical Corp. Announces CEO Transition and Strategic Investor Alignment
Cardiol closes $14.85-million bought deal financing
Bionxt Solutions to issue six million shares for debt
Bausch Health's RED-C trials fail to meet end point
TempraMed Launches New Product "VIVI Med(TM)," Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications
Aja Health and Wellness Inc. Announces Agreement Between Assured Diagnosis Inc. and Greatway Financial Inc. and Implementation of New Electronic Medical Records Software for GOeVisit
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
Thiogenesis Presents Phase 2 (EU) MELAS Data at Mitocon 2026